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Cerebral autosomal dominant arteriopathy with subcortical infarct and
leukoencephalopathy (CADASIL) is a Notch3 mutation-induced cerebral small
vessel disease, leading to recurrent ischemic stroke and vascular dementia. There
is currently no treatment that can stop or delay CADASIL progression. We have
demonstrated the efficacy of treatment with combined stem cell factor (SCF) and
granulocyte colony-stimulating factor (G-CSF) (SCF+G-CSF) in reducing cerebral
small vessel thrombosis in a TgNotch3R90C mouse model of CADASIL. However, it
remains unknown whether SCF+G-CSF treatment protects neurons from microvascular
thrombosis-induced ischemic damage. Using bone marrow transplantation to track
thrombosis, we observed that capillary thrombosis was widely distributed in the
cortex, striatum and hippocampus of 22-month-old TgNotch3R90C mice. However,
the capillary thrombosis mainly occurred in the cortex. Neuron loss was seen in the
area next to the thrombotic capillaries, and severe neuron loss was found in the
areas adjacent to the thrombotic capillaries with bifurcations. SCF+G-CSF repeated
treatment significantly attenuated neuron loss in the areas next to the thrombotic
capillaries in the cortex of the 22-month-old TgNotch3R90C mice. Neuron loss caused
by capillary thrombosis in the cerebral cortex may play a crucial role in the pathogenesis
of CADASIL. SCF+G-CSF treatment ameliorates the capillary thrombosis-induced
ischemic neuron loss in TgNotch3R90C mice. This study provides new insight into the
understanding of CADASIL progression and therapeutic potential of SCF+G-CSF in
neuroprotection under microvascular ischemia in CADASIL.
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INTRODUCTION

MATERIALS AND METHODS

Cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL) is the most
common monogenic cause of stroke and vascular dementia in
adults (Chabriat et al., 2009). Currently, the pathogenesis of
CADASIL remains poorly understood, and there is no treatment
that can stop or delay CADASIL progression.
CADASIL is caused by mutations in the NOTCH3 gene
(Joutel et al., 1996). NOTCH3-encoded Notch3 receptor
is predominantly expressed in vascular smooth muscle
cells (VSMCs) of small arteries (Wang et al., 2012) and
pericytes of capillaries (Wang et al., 2014). Due to the
specific distribution of Notch3, the typical pathologies
in the brain are mainly found in small arteries and
capillaries in both CADASIL patients and mouse models
(Joutel, 2011). Pathological changes in endothelial cells
(ECs) have been observed in CADASIL patients and the
TgNotch3R90C mouse model of CADASIL (Ruchoux and
Maurage, 1998; Ping et al., 2018, 2019). It has also been
revealed that disrupted blood-brain barrier (BBB) integrity
(Ping et al., 2018), increased thrombosis in cerebral small
vessels (Ping et al., 2018), reduced cerebral blood vessel
density (Liu et al., 2015; Ping et al., 2019) and impaired
endothelium-dependent vasodilation (Stenborg et al., 2007)
occur in CADASIL patients and TgNotch3R90C mice.
Endothelial dysfunction is crucially involved in vascular
ischemia as ECs shift from an anti-thrombotic to a prothrombotic stage when their function is dysregulated
(Yau et al., 2015).
Cerebral microcirculation plays a vital role in brain
health. Cerebral capillaries with a total length of ∼400 miles
in humans are the primary site of oxygen, nutrient and
metabolic exchange (Cipolla, 2009). Cerebral microcirculation
impairment is a central pathology in Alzheimer’s dementia
(Iadecola, 2015; van de Haar et al., 2015), while it remains
unclear about the pathological role of cerebral microvascular
impairment in CADASIL. There is a knowledge gap about
the involvement of cerebral capillary thrombosis in ischemic
neuronal death in CADASIL.
Stem cell factor (SCF) and granulocyte colony-stimulating
factor (G-CSF) are the essential hematopoietic growth factors
regulating blood cell production and bone marrow stem cell
survival (Welte et al., 1985; Zsebo et al., 1990). Recently,
we have demonstrated that SCF+G-CSF treatment ameliorates
cerebrovascular endothelial cell (EC) damage and reduces
cerebral capillary thrombotic formation in TgNotch3R90C mice
(Ping et al., 2018, 2019). In addition, SCF+G-CSF treatment
has been shown to reduce infarction size in acute ischemic
stroke in a rat model of focal cerebral ischemia (Zhao
et al., 2007b). However, whether SCF+G-CSF treatment could
enhance neuronal survival in the area of thrombotic capillary
remains elusive.
This study aims to determine the distribution of capillary
thrombosis in the brain, the existence of cerebral capillary
thrombosis-caused ischemic neuron loss, and the efficacy of
SCF+G-CSF treatment in reducing microvascular ischemic
damage in TgNotch3R90C mice.

Animals and Treatments
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All procedures in this study were approved by Institutional
Animal Care and Use Committee at SUNY Upstate
Medical University and LSUHSC.
Transgenic mice (TgNotch3R90C) carrying a full-length
human NOTCH3 gene with the Arginine-to-Cysteine
(Arg90Cys) mutation driven by the SM22α promoter were
used as a mouse model of CADASIL (Ruchoux et al., 2003). The
original breeders were generously provided as gifts from Dr.
Anne Joutel (Faculté de Médecine, Paris, France). Eight-monthold male TgNotch3R90C mice were randomly divided into two
groups: a vehicle control group and an SCF+G-CSF-treated
group. All mice received a lethal dose of radiation (900 rad) to
destroy their own bone marrow. Within 24 h after irradiation,
bone marrow isolated from transgenic mice ubiquitously
expressing enhanced green fluorescent protein (GFP) (UBC-GFP
mice) was transplanted to the irradiated mice. One month after
bone marrow transplantation, the first treatment of SCF+G-CSF
was initiated at 9 months of age, which is 1 month before
cerebrovascular dysfunction is shown in TgNotch3R90C mice
(Ruchoux et al., 2003; Lacombe et al., 2005). Recombinant mouse
SCF (100 µg/kg, diluted with saline) (PeproTech, Rocky Hill,
NJ, United States) and recombinant human G-CSF (50 µg/kg,
diluted with 5% dextrose) (Amgen, Thousand Oaks, CA,
United States) were subcutaneously administered for 5 days.
An equal volume of vehicle solution (50% saline and 50% of
5% dextrose) was injected into the control mice. The same
treatment was then repeated an additional 4 times at the ages
of 10, 12, 15, and 20 months. The final treatment was given at
200 µg/kg of SCF and 50 µg/kg of G-CSF to further enhance
the effectiveness. Mice were euthanized at the age of 22 months
(n = 5/group) (Figure 1A).

Bone Marrow Transplantation
The bone marrow of UBC-GFP mice (C57BL/6 background)
was transplanted into the TgNotch3R90C mice (C57BL/6
background) to track blood clots (thrombosis) in the cerebral
capillaries of TgNotch3R90C mice. UBC-GFP mice (male, 6 to
8 weeks old, Jackson Laboratory) were anesthetized with Avertin
(0.4 g/kg body weight, intraperitoneally) (Sigma-Aldrich, St.
Louis, MO, United States) and euthanized. The femur bones
were dissected and placed into a cell culture dish with icecold sterile Hanks Balanced Salt Solution (HBSS) (ThermoFisher
Scientific, Pittsburgh, PA, United States). Bone marrow cells were
flushed out, gently triturated, and filtered through a 70 µm nylon
mesh (Corning, Fisher Scientific, Pittsburgh, PA, United States).
Harvested cells were centrifuged, re-suspended with HBSS into
single cell suspension and then transplanted to the irradiated
TgNotch3R90C mice by tail vein injection (1 × 107 bone marrow
cells in 0.6 ml HBSS per mouse).

Brain Tissue Preparation and
Immunohistochemistry
After being anesthetized with Avertin (0.4 g/kg,
intraperitoneally), mice were euthanized by transcardiac
2
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FIGURE 1 | Capillary thrombosis is mainly located in the cortex of TgNotch3 mice. (A) Schematic diagram of the experiment. Eight-month-old TgNotch3R90C mice
received lethal dose irradiation and bone marrow transplantation. At 9 months of age, mice received subcutaneous (s.c.) injections of SCF+G-CSF or vehicle solution
for 5 days. The same treatment was repeatedly administered at the age of 10, 12, 15, and 20 months. All the mice were euthanized at the age of 22 months
(n = 5/group). (B) A pie chart displays the percentage of thrombotic capillaries in the brain of 22-month-old TgNotch3R90C mice. The thrombotic capillaries were
detected by GFP expressing blood cells that occluded capillaries. (C) Representative confocal image shows that GFP expressing blood cells occlude capillaries
(<10 mm in diameter) in the cerebral cortex of a 22-month-old TgNotch3R90C mouse. (D) Three-dimensional image shows the capillary occluded by GFP
expressing blood cells. Three different layers were selected to show that the capillary was completely occluded by GFP expressing blood cells. (E,F)
Three-dimensional images illustrate that GFP expressing blood cells occlude a cerebral capillary at two different longitudinal layers [see the areas labeled with (E,F) in
panel D]. (G) Three-dimensional image illustrates that GFP expressing blood cells occlude a cerebral capillary in a transverse view [see the area labeled with (G) in
panel D]. Scale bars, 50 µm in panel (C) and 5 µm in panels (D–G).

perfusion of phosphate-buffered saline (PBS) (ThermoFisher
Scientific, Pittsburgh, PA, United States) containing heparin
(10 U/ml, Sagent Pharmaceuticals) followed by 10% neutral
buffered formalin (Sigma-Aldrich, St. Louis, MO, United States).

Frontiers in Cell and Developmental Biology | www.frontiersin.org

Brains were removed and post-fixed in the same fixative solution
overnight at 4◦ C, and then dehydrated in 30% sucrose solution
(Sigma-Aldrich, St. Louis, MO, United States) in PBS for 2 days
at 4◦ C. Brains were sectioned at a thickness of 30 µm using

3
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(capillaries: <10 µm in diameter) through immunofluorescence
double staining of CD31 (EC marker) and GFP (bone marrowderived blood cells). We observed that capillary thrombosis was
randomly located in the brain. The most capillary thrombosis
was seen in the cortex, which accounted for 62.3% of total
occluded capillaries. The frequency of capillary thrombosis in the
striatum and hippocampus was 26.1% and 11.6%, respectively,
(Figure 1B). To further confirm that the capillaries were occluded
by blood cells, three dimensional images were captured with
a confocal microscope. We found that the occluded capillaries
were filled with GFP positive bone marrow-derived blood cells
(Figures 1C–G), indicating that capillary thrombosis occurs in
the brains of TgNotch3R90C mice.

a Cryostat (Leica Biosystems, Wetzlar, Germany). All brain
sections were stored at −20◦ C with anti-freeze buffer containing
30% ethylene glycol and 30% glycerol (Sigma-Aldrich, St.
Louis, MO, United States) prepared in PBS until used for
immunohistochemistry.
Two brain sections per mouse (bregma 0.02 mm to
−1.82 mm) were used for immunohistochemistry. After brain
sections were rinsed with PBS, nonspecific binding was
blocked with 10% donkey serum prepared in 1% bovine
serum albumin (BSA, IgG free, Jackson ImmunoResearch
Laboratories, West Grove, PA, United States) and 0.3% Triton
X-100 (Sigma-Aldrich, St. Louis, MO, United States) solution
for 1 h at room temperature. For the primary antibodies
from mouse origin, brain sections were further blocked with
mouse-on-mouse blocking reagent (M.O.MTM , Vectashield,
Vector Laboratories, Burlingame, CA, United States). Brain
sections were incubated with rat anti-mouse CD31 (1:50)
(BD biosciences, San Jose, CA, United States), mouse antimouse NeuN (1:600) (ThermoFisher Scientific, Pittsburgh,
PA, United States) and goat anti-mouse GFP (1:600) (Novus
Biologicals, Littleton, CO, United States) primary antibodies
at 4◦ C overnight. The next day, brain sections were washed
with PBS and then incubated with the appropriate secondary
antibody for 2 h at room temperature in the dark. The
secondary antibodies used were Alexa Fluor 594-conjugated
donkey anti-rat (1:500), Alexa Fluor 594-conjugated donkey
anti-mouse (1:500) and Alexa Fluor 488-conjugated donkey
anti-goat (1:500) (ThermoFisher Scientific, Pittsburgh, PA,
United States). The antibodies were all diluted in PBS containing
1% BSA and 0.3% TritonX-100. Nuclei were stained with
mounting medium (VECTASHIELD) containing DAPI (Vector
Laboratories, Burlingame, CA, United States). Images were taken
with a Zeiss 780 confocal microscope (Carl Zeiss Microscopy,
LLC, Thornwood, NY, United States).

SCF+G-CSF Treatment Attenuates
Neuron Loss in the Areas Next to
Thrombotic Capillaries in the Cortex of
TgNotch3R90C Mice
Next, we sought to determine the involvement of capillary
thrombosis in neuronal damage and the effect of SCF+G-CSF
treatment in neuroprotection in the brains of TgNotch3R90C
mice. First, we quantified the number of neurons in the cortex,
striatum and hippocampus through NeuN immunostaining.
We observed that the number of NeuN positive neurons was
not significantly different between the SCF+G-CSF-treated and
non-treated TgNotch3R90C mice in the cortex, striatum and
hippocampus (Figures 2A–D). We then quantified the number
of NeuN positive neurons in the microareas next to the occluded
capillaries (the microarea = 50 µm from the center of occluded
capillary × the length of occluded capillary) in the cerebral cortex
of TgNotch3R90C mice (Figures 2E–I). We selected the cortex
for determining capillary thrombosis-induced neuron damage
due to its high frequency of capillary thrombosis. We found
that the number of NeuN positive neurons was significantly
decreased in the areas next to the thrombotic capillaries with
bifurcation as compared to areas adjacent to the thrombotic
capillaries without bifurcation (Figures 2E and H, p < 0.05).
In the areas next to the thrombotic capillaries with nonbifurcation, SCF+G-CSF treatment significantly increased the
number of NeuN positive neurons (Figures 2F and I, p < 0.01).
Moreover, the number of NeuN positive neurons was also
significantly increased in the areas adjacent to the thrombotic
capillaries with the bifurcation after SCF+G-CSF treatment
(Figures 2G and I, p < 0.05). However, SCF+G-CSF treatmentenhanced neuron survival was more robust in the microareas
next to thrombotic capillaries without bifurcation than in
the microareas next to thrombotic capillaries with bifurcation
(Figure 2I, p < 0.05). These data indicate that the structure of
cortical capillaries may influence the microenvironment in the
brains of the TgNotch3R90C mice, which affects the severity
of capillary thrombosis-caused ischemic neuron damage. The
findings also demonstrate that SCF+G-CSF treatment protects
neurons from ischemic injury caused by capillary thrombosis
in the cortex of TgNotch3R90C mice. The extent of SCF+GCSF-enhanced neuron survival in the microareas next to the

Statistical Analysis
Data analysis was performed in a blinded manner. Two-group
comparisons were analyzed using a student t-test based on
the distribution of sample data. Two-way analysis of variance
(ANOVA) followed by LSD post hoc multiple comparison tests
were used to analyze two factor comparisons. All the data
are presented as mean ± standard error of mean (SEM), and
results were considered significantly different when a p-value
was less than 0.05. Analyses were performed, and data were
displayed using Prism software (GraphPad Software, Inc., La
Jolla, CA, United States).

RESULTS
Most Capillary Thrombosis in the Brains
of TgNotch3R90C Mice Occurs in the
Cortex
We first examined the distribution of the capillary thrombosis in
the brains of TgNotch3R90C mice by detecting bone marrowderived GFP positive blood cells that occluded the capillaries

Frontiers in Cell and Developmental Biology | www.frontiersin.org

4

January 2021 | Volume 8 | Article 627733

Ping et al.

SCF+G-CSF Reduces Neuron Loss in CADASIL

FIGURE 2 | SCF+G-CSF treatment attenuates neuron loss in the areas next to the thrombotic capillaries in the cerebral cortex of TgNotch3R90C mice. Detection of
neuron loss: NeuN positive neurons were quantified within the white dotted square area which is 50 µm adjacent to the occluded capillaries. (A) Representative
confocal images show NeuN positive neurons in the cerebral cortex, striatum and hippocampus of TgNotch3R90C mice with or without SCF+G-CSF treatment.
Red: NeuN positive neurons. Blue: DAPI nuclear counterstain. (B–D) Statistical analysis data show that the number of NeuN positive neurons in the cortex, striatum
and hippocampus of 22-month-old TgNotch3R90C mice has no difference between vehicle controls and SCF+G-CSF-treated mice. (E) Representative confocal
images show NeuN positive neurons in the microareas adjacent to the thrombotic capillaries with or without bifurcation. Red: NeuN positive cells. Green: GFP
expressing blood cells that occlude capillaries. (F) Representative confocal images show NeuN positive neurons adjacent to the thrombotic capillaries without
bifurcation in the cortex of TgNotch3R90C mice with or without SCF+G-CSF treatment. (G) Representative confocal images illustrate NeuN positive neurons next to
the thrombotic capillaries with bifurcations in the cortex of TgNotch3R90C mice with or without SCF+G-CSF treatment. (H) Statistical analysis data show that the
number of NeuN positive neurons in the areas next to the thrombotic capillaries with bifurcation is significantly decreased as compared with the areas next to the
thrombotic capillaries without bifurcation in the cortex of all 22-month-old TgNotch3R90C mice including both SCF+G-CSF treated and non-treated mice.
(I) Two-way ANOVA statistical analysis data show that SCF+G-CSF treatment significantly enhances neuron survival in both the areas adjacent to the thrombotic
capillaries with and without bifurcation. The SCF+G-CSF-enhanced neuron survival is more robust in the area of thrombotic capillaries without bifurcation than in the
area of thrombotic capillaries with bifurcation. N = 5. *p < 0.05, **p < 0.01.

thrombotic capillaries is also influenced by the structure of the
thrombotic capillary.

next to the thrombotic capillary, (2) the neuron loss becomes
more severe in the areas adjacent to the thrombotic capillaries
with bifurcations, and (3) SCF+G-CSF treatment ameliorates the
neuron loss adjacent to the thrombotic capillaries in the cerebral
cortex of 22-month-old TgNotch3R90C mice (Figure 3).
We employed the bone marrow transplantation in this study
to track blood cells in the cerebral capillary thrombosis. Before
the bone marrow transplantation, all the mice received a lethal
dose (900 rad) of radiation to ablate their bone marrow. This
bone marrow transplantation approach has been successfully

DISCUSSION
In the present study, we have identified that the majority of
capillary thrombosis in the brain of TgNotch3R90C mice occurs
in the cortex. We have also, for the first time, demonstrated
that (1) microscopically detectable neuron loss exists in the area
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hemorrhage in cerebral small vessels leads to CADASIL-caused
lacunar infarcts because microbleeds are observed in CADASIL
patient’s brain but there is a lack of evidence that supports
thrombotic genesis of ischemic events (Di Donato et al., 2017).
Here we have provided key evidence revealing that capillary
thrombosis occurs in the brains of mice carrying CADASILrelated Notch3 mutations and that the capillary thrombosis leads
to ischemic neuron loss.
In TgNotch3R90C mice, degenerating ECs and impaired
cerebrovascular function are found as early as 10 months of
age (Ruchoux et al., 2003; Lacombe et al., 2005). Our previous
study has shown EC damage and thrombosis in the cerebral
capillaries and small vessels of 22-month-old TgNotch3R90C
mice (Ping et al., 2018), suggesting that endothelial dysfunctioninduced thrombosis occurs in the cerebral microvessels because
ECs shift from an anti-thrombotic to a prothrombotic stage when
their function is dysregulated (Yau et al., 2015). The underlying
mechanism of EC degeneration/damage in CADASIL remains
elusive. It is well documented that VSMCs and pericytes are
required for maintaining vascular function and stabilization
(Franco et al., 2011; Miyagawa et al., 2019). Pharmacological
or genetic ablation of pericytes leads to reduced EC survival,
BBB breakdown and vascular degeneration (Franco et al., 2011;
Winkler et al., 2011). In our earlier studies, we have observed
the autophagic degeneration of capillary pericytes and capillary
EC degeneration/damage in the cerebral cortex of 22-monthold TgNotch3R90C mice (Gu et al., 2012; Ping et al., 2018),
suggesting that capillary EC degeneration/damage in the brains
of 22-month-old TgNotch3R90C mice is associated with capillary
pericyte degeneration.
Our data have also revealed that the majority of bloodoccluded capillaries are located in the cerebral cortex, and
that neuron loss occurs in the areas next to the thrombotic
capillaries in TgNotch3R90C mice. These observations are in
line with clinical findings revealing microinfarcts in the cortex
of CADASIL patients (Jouvent et al., 2011; De Guio et al.,
2014). These findings renew the traditional notion that CADASIL
only affects the subcortical white matters (Dichgans, 2002),
and provide insightful evidence demonstrating that capillary
thrombosis-caused ischemic damage in the cerebral cortex may
play a crucial role in the pathogenesis of CADASIL.
It remains unclear why the capillary thrombosis is mainly
located in the cortex, instead of the striatum and hippocampus.
It has been documented that the topological distribution of the
capillary network is different throughout the brain to match
the regional metabolism (Shaw et al., 2019; Zhang et al., 2019).
The vascular network shows distinct distribution and density in
the cortex, hippocampus and striatum. The cortical parenchyma
is full of abundant vessels, which are well arranged into a
mesh-like network. The vascular density in the hippocampus is
significantly lower than the cortical vessel density (Zhang et al.,
2019). No obvious difference of vascular density is seen between
the striatum and cortex (Di Giovanna et al., 2018). Based on these
studies, we postulate that the different varieties of metabolic rates
with the different distribution and density of vascular network in
different brain regions may influence the formation of capillary
thrombosis in the TgNotch3R90C mice.

FIGURE 3 | Graphic summary of the findings in this study. (A) The majority of
capillary thrombosis is seen in the cerebral cortex of 22-month-old
TgNotch3R90C mice. (B) Neuron loss occurs in the area next to thrombotic
capillaries. The neuron loss becomes more severe in the areas of thrombotic
capillaries with bifurcations. SCF+G-CSF treatment attenuates the neuron loss
adjacent to the thrombotic capillaries in the cerebral cortex of 22-month-old
TgNotch3R90C mice.

used for tracking bone marrow-derived cells in our previous
studies (Piao et al., 2009; Li et al., 2011; Liu et al., 2015). It has been
well documented that transplantation of a genetically identical
graft (syngeneic graft or autologous bone marrow) does not lead
to rejection (Duran-Struuck and Dysko, 2009). The UBC-GFP
mice (bone marrow donors) and TgNotch3R90C mice (bone
marrow recipients) both have C57BL/6 genetic background.
The bone marrow transplantation was performed within 24 h
after irradiation. In the present study, we did not observe bone
marrow failure or the graft-versus-host disease in TgNotch3R90C
mice. The commonly used C57BL/6 mice have been shown to
tolerate the radiation doses of 1,000 to 1,100 rad (Duran-Struuck
et al., 2008). In the current study, we did not see irradiationinduced injury in TgNotch3R90C mice. Taken together, all the
TgNotch3R90C mice used in this study were in good condition
after irradiation and bone marrow transplantation.

Capillary Thrombosis Leads to Local
Neuron Damage in the Brains of
TgNotch3R90C Mice
Our data show that capillary thrombosis is widely distributed
in the cerebral cortex, striatum and hippocampus of 22month-old TgNotch3R90C mice. These findings are consistent
with our earlier study (Ping et al., 2018) revealing EC
degeneration/damage-induced cerebral capillary thrombosis in
22-month-old TgNotch3R90C mice. These observations suggest
that cerebral capillary thrombosis is involved in the pathogenesis
of CADASIL. It has been questioned whether thrombosis or
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ages of TgNotch3R90C mice, the capillary thrombosis-induced
ischemic neuron loss at different locations may be under
different post-ischemic stages/phases. SCF+G-CSF treatment
may exert its universal protection against neuron death from the
different stages/phases.
The
mechanism
underlying
SCF+G-CSF-enhanced
neuroprotection in different phases of cerebral ischemia
remains unclear. Expression of receptors for SCF (Zhao et al.,
2007b) and G-CSF (Schneider et al., 2005) on neurons reflects
their direct efficacy in neuroprotection. In cultured primary
cortical neurons, SCF protects neurons from excitotoxicity
through MEK/ERK and PI3K/AKT/NF-kB pathways and from
apoptosis through PI3K/AKT/NF-kB/Bcl-2 signaling, and the
SCF-enhanced neuroprotection is dependent on its receptor
(c-kit) expression (Dhandapani et al., 2005). G-CSF receptor,
G-CSFR, is robustly expressed in the peri-infarct neurons of rat
brain (Schneider et al., 2005) and human brain (Hasselblatt et al.,
2007) in the acute phase of ischemic stroke. G-CSF counteracts
programmed neuron death via PI3K mediation in cultured
cortical neurons (Schneider et al., 2005).
In addition to the direct effects of SCF and G-CSF in
neuroprotection demonstrated in in vitro studies, many in vivo
studies have revealed that SCF and G-CSF may protect the brain
from post-ischemic neuron loss through an indirect way. It has
been shown that brain ischemia-triggered neuroinflammation in
both the acute and subacute phases leads to secondary neuron
loss including apoptotic neuron death (Duris et al., 2018; Jayaraj
et al., 2019). G-CSF treatment in the acute phase of focal
cerebral ischemia suppresses pro-inflammatory cytokines and
inflammatory mediators in the peri-ischemic areas (Gibson et al.,
2005; Sehara et al., 2007), reduces the disruption of the BBB (Lee
et al., 2005), inhibits peripheral inflammatory cell infiltration to
the ischemic hemisphere (Lee et al., 2005) and reduces neuronal
apoptosis in the ipsilesional cortex (Solaroglu et al., 2006).
SCF+G-CSF treatment in the subacute phase of focal cerebral
ischemia upregulates IL-10, an anti-inflammatory cytokine, in
the ipsilesional cortex (Morita et al., 2007). In our earlier
study, the level of vascular endothelial growth factor (VEGF) is
decreased in the brains of TgNotch3R90C mice, while SCF+GCSF treatment increases cerebral VEGF in TgNotch3R90C mice
(Ping et al., 2019). Intracerebral injection of VEGF reduces infarct
volume in focal cerebral ischemia, and the direct effect of VEGF
in neuroprotection is also demonstrated in in vitro hypoxia
models (Greenberg and Jin, 2013). It would be possible that
increased cerebral VEGF may also contribute to the SCF+GCSF-induced neuroprotection in the area of capillary thrombosis
in TgNotch3R90C mice.
Our previous studies have demonstrated that repeated
treatments with SCF+G-CSF reduce cerebral capillary
thrombosis, attenuate capillary thrombosis in the bifurcation
regions (Ping et al., 2018), enhance angiogenesis and increase
blood vessel density in the brains of TgNotch3R90C mice (Liu
et al., 2015; Ping et al., 2019), which may lead to increasing
collateral circulation and ameliorating ischemic damage in the
areas next to the thrombotic capillaries. Our present findings
reveal that SCF+G-CSF-reduced neuron loss is more robust
in the areas with a single thrombotic capillary than the areas

Vascular occlusion and hemorrhage are the vascular events
that lead to regional neuronal death (i.e., infarcts) (Nishimura
and Schaffer, 2013). Here we have observed that blood clots
completely occlude the capillaries, demonstrating the formation
of capillary occlusion (i.e., capillary thrombosis). The occlusion
of capillaries prevents blood flow from reaching a small territory
of brain tissue leading to ischemic damage and local neuron
death. Our findings have also revealed that neuron loss is
increased in the microareas next to the occluded capillaries
with bifurcations as compared to the microareas adjacent to
the occluded capillaries without bifurcations, indicating that the
severity of ischemia-induced neuron loss is capillary structurerelated. In the cerebral vasculature, the number of vascular
branches is dramatically increased in the capillaries as compared
with other types of blood vessels (Reina-De La Torre et al.,
1998). The bifurcation is the major junction in the capillary bed
(Gould et al., 2017). Blood flow starts from the arterial inlet and
makes random choices at each bifurcation, making the blood flow
complex at the site of the bifurcation; as a result, it leads to the
ECs in the bifurcation area being more vulnerable to damage
in the presence of risk factors for vascular diseases (De Syo
et al., 2005). It is possible that once the thrombotic occlusions
occur at the bifurcation site of the capillary network, two or
more downstream capillaries will be affected, which leads to an
increased severity of ischemia and neuronal loss in the territory
of affected capillaries.

SCF+G-CSF Treatment Ameliorates
Ischemic Neuron Loss in the Area Next
to the Thrombotic Capillary
In the present study, SCF+G-CSF treatment-reduced neuronal
loss has been observed in the areas adjacent to the thrombotic
capillaries, demonstrating the neuroprotective efficacy of
SCF+G-CSF on capillary thrombosis-induced ischemic damage
in the brains of TgNotch3R90C mice. The effects of SCF and
G-CSF in neuroprotection have been reported in focal cerebral
ischemia. Focal cerebral ischemia is produced by occlusion of a
relatively large artery, the middle cerebral artery (MCA), leading
to massive brain tissue loss (i.e., infarct) in the territory of the
occluded MCA. In rodent models of focal cerebral ischemia,
systemic administration of SCF (Zhao et al., 2007b), G-CSF
(Schneider et al., 2005; Zhao et al., 2007b), and SCF+G-CSF
(Kawada et al., 2006; Zhao et al., 2007b) initiated in the acute
phase of ischemic stroke (<48 h after MCA occlusion) results
in the reduction of infarction size. Strikingly, subcutaneous
injection of SCF+G-CSF in the subacute phase (during 11–
20 days post-ischemia) (Kawada et al., 2006) or in the chronic
phase (14 weeks post-ischemia) (Zhao et al., 2007a) of ischemic
stroke still shows significant reductions of infarct volume. These
studies have demonstrated the effectiveness of SCF+G-CSF
treatment in protecting neurons from both acute ischemic
damage and the focal cerebral ischemia-induced long-term
progressive neuron loss. In contrast to stroke that occurs as a
sudden event, CADASIL causes progressive damage in cerebral
small arteries and capillaries, leading to progressive thrombosis
in these vessels. Most likely, when we give treatment to different
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with multiple thrombotic capillaries (i.e., thrombotic capillaries
with bifurcations). These findings suggest that the increase of
collateral circulation by SCF+G-CSF may be more sufficient to
rescue neurons from the microareas without severe ischemic
damage than from the microareas with severe ischemic damage
due to having multiple thrombotic capillaries.
In conclusion, this study provides new and important
evidence demonstrating that capillary thrombosis-caused
microvascular ischemic damage exists in the brains of 22month-old TgNotch3R90C mice. The thrombotic capillaries
are mainly located in the cortex, and the capillary thrombosis
leads to local neuron loss. Systematic administration of
SCF+G-CSF attenuates neuron loss in the areas next to
the thrombotic capillaries. These findings advance toward
an understanding of the pathological role of cortical
capillary thrombosis-caused microvascular ischemia in the
pathogenesis of CADASIL and reveal a new therapeutic
target for developing treatment to ameliorate microvascular
ischemia in CADASIL.
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